These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8576300)

  • 1. Evaluation of 4 commercial test kits for parvovirus B19-specific IgM.
    Cohen BJ; Bates CM
    J Virol Methods; 1995 Sep; 55(1):11-25. PubMed ID: 8576300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of two commercial enzyme immunoassays for serodiagnosis of human parvovirus B19 infection.
    Enders M; Helbig S; Hunjet A; Pfister H; Reichhuber C; Motz M
    J Virol Methods; 2007 Dec; 146(1-2):409-13. PubMed ID: 17854916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of seven commercial tests for the detection of parvovirus B19-specific IgM.
    Schwarz TF; Jäger G; Gilch S
    Zentralbl Bakteriol; 1997 Apr; 285(4):525-30. PubMed ID: 9144914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of three recombinant antigen-based enzyme immunoassays for detection of IgM and IgG antibodies to human parvovirus B19.
    Pickering JW; Forghani B; Shell GR; Wu L
    Clin Diagn Virol; 1998 Jan; 9(1):57-63. PubMed ID: 9562859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facial rash in a pregnant woman.
    Waugh S; Brown KE
    J Clin Virol; 2009 Oct; 46(2):105-6. PubMed ID: 19716763
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of clinical, molecular, and serological features in the diagnosis of parvovirus B19 infection in children.
    Onel M; Varkal MA; Yildiz I; Guven O; Unuvar E; Uysal HK; Agacfidan A
    Diagn Microbiol Infect Dis; 2024 Aug; 109(4):116300. PubMed ID: 38759541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant human parvovirus B19 antigens in serological assays.
    Cubie HA; Leslie EE; Smith S; O'Neill HJ; Hart H; Cohen BJ; Inglis JM
    J Clin Pathol; 1993 Sep; 46(9):840-5. PubMed ID: 8227436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of parvovirus B19 infection by detection of specific immunoglobulin M antibody in saliva.
    Cubel RC; Oliveira SA; Brown DW; Cohen BJ; Nascimento JP
    J Clin Microbiol; 1996 Jan; 34(1):205-7. PubMed ID: 8748306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19.
    Sloots T; Devine PL
    Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):758-61. PubMed ID: 8922581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged parvovirus b19 viremia in spite of neutralizing antibodies after erythema infectiosum in pregnancy.
    Dobec M; Juchler A; Flaviano A; Kaeppeli F
    Gynecol Obstet Invest; 2007; 63(1):53-4. PubMed ID: 16940737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fluid: Non-invasive alternative for parvovirus B19 diagnosis?
    Bodewes R; Kerkhof J; Cremer J; Gijselaar DB; Voordouw BCG; Veldhuijzen IK; Schipper M; van Binnendijk R
    J Clin Virol; 2019 Aug; 117():5-10. PubMed ID: 31128380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A school outbreak of parvovirus B19 infection investigated using salivary antibody assays.
    Rice PS; Cohen BJ
    Epidemiol Infect; 1996 Jun; 116(3):331-8. PubMed ID: 8666078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.
    Gray JJ; Cohen BJ; Desselberger U
    J Virol Methods; 1993 Sep; 44(1):11-23. PubMed ID: 8227275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Observations on human parvovirus B19 infection diagnosed in 2011].
    Mihály I; Trethon A; Arányi Z; Lukács A; Kolozsi T; Prinz G; Marosi A; Lovas N; Dobner IS; Prinz G; Szalai Z; Pék T
    Orv Hetil; 2012 Dec; 153(49):1948-57. PubMed ID: 23204301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Responsiveness of a new parvovirus B19 antigen produced in baculovirus expression system to B19-specific IgG and IgM antibodies in every epidemic, 1968, 1980, 1987 and 1992 in Japan].
    Nunoue T
    Kansenshogaku Zasshi; 1995 May; 69(5):546-52. PubMed ID: 7602188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
    Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
    Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics.
    Enders M; Schalasta G; Baisch C; Weidner A; Pukkila L; Kaikkonen L; Lankinen H; Hedman L; Söderlund-Venermo M; Hedman K
    J Clin Virol; 2006 Apr; 35(4):400-6. PubMed ID: 16332455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory diagnosis of parvovirus B19 infection.
    Sevall JS; Ritenhous J; Peter JB
    J Clin Lab Anal; 1992; 6(4):171-5. PubMed ID: 1403335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Laboratory diagnosis of parvovirus B 19 infection: comparison of ten commercial IgG- and IgM-antibody tests].
    Helftenbein E; Kunz H; Hartter P
    Immun Infekt; 1994 Oct; 22(5):181-6. PubMed ID: 7982714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Parvovirus B19 infection: the general aspects and gestational problems].
    Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
    Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.